Company Description

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States.

The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights.

The company was founded in 2016 and is headquartered in Freehold, New Jersey.

Avalon GloboCare Corp.

Country	United States
Founded	2014
Industry	Real Estate Services
Sector	Real Estate
Employees	4
CEO	Dr. David K. Jin M.D., Ph.D.

Contact Details

Address: 4400 Route 9, Suite 3100 Freehold, New Jersey 07728 United States
Phone	732-780-4400
Website	avalon-globocare.com

Stock Details

Ticker Symbol	ALBT
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001630212
CUSIP Number	05344R203
ISIN Number	US05344R2031
Employer ID	47-1685128
SIC Code	2836

Key Executives

Name	Position
Dr. David K. Jin M.D., Ph.D.	Chief Executive Officer, President and Director
Luisa Ingargiola	Chief Financial Officer
Meng Li	Chief Operating Officer, Chief Marketing Officer and Secretary

Latest SEC Filings

Date	Type	Title
Jun 5, 2024	8-K	Current Report
May 31, 2024	10-Q	Quarterly Report
May 24, 2024	8-K	Current Report
May 15, 2024	NT 10-Q	Notification of inability to timely file Form 10-Q or 10-QSB
May 7, 2024	8-K	Current Report
Apr 15, 2024	10-K	Annual Report
Apr 1, 2024	NT 10-K	Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 27, 2024	8-K	Current Report
Jan 25, 2024	SC 13D/A	[Amend] General statement of acquisition of beneficial ownership
Nov 22, 2023	8-K	Current Report

View All SEC Filings